Which statin has the least amount of side effects
Pro Research Analysisby 
Searched over 200M research papers
Statins with the Least Amount of Side Effects
Statins are widely prescribed for lowering cholesterol and preventing cardiovascular diseases. However, concerns about their side effects persist. This article synthesizes research findings to identify which statin has the least amount of side effects.
Common Side Effects of Statins
Muscle-Related Side Effects
Muscle pain, known as myalgia, is the most common side effect of statin use, affecting 1-10% of patients. More severe muscle damage, such as myopathy and rhabdomyolysis, is rare but can occur, especially at higher doses or with interacting drugs . Myopathy typically affects fewer than one in 10,000 patients on standard doses.
Liver Function
Statins can cause asymptomatic increases in liver transaminases in up to 1% of patients, but this is not usually associated with significant liver disease . Transient increases in liver enzymes occur in 0.5-2% of patients but are generally not clinically relevant.
Diabetes Risk
Statin therapy is associated with a modest increase in the risk of new-onset diabetes, particularly in patients with metabolic syndrome or prediabetes . However, pitavastatin has not been linked to an increased risk of diabetes, making it a potentially safer option for patients concerned about this side effect.
Cognitive and Renal Function
Statins do not adversely affect cognitive function or cause significant deterioration in renal function. Concerns about cognitive decline have not been supported by substantial evidence.
Statins with the Least Side Effects
Pitavastatin
Pitavastatin stands out as having a lower risk of inducing diabetes compared to other statins. This makes it a preferable choice for patients at risk of developing diabetes.
General Safety Profile
Overall, statins are considered safe for the majority of patients, with the benefits of cardiovascular protection outweighing the risks of side effects . The side effects are generally mild and manageable, and severe adverse effects are rare.
Conclusion
While all statins have a similar safety profile, pitavastatin may have a slight edge due to its lower association with diabetes risk. For most patients, the cardiovascular benefits of statins far outweigh the potential for adverse effects. Regular monitoring and appropriate dosing can further minimize risks, ensuring that statin therapy remains a cornerstone in the prevention and treatment of cardiovascular diseases.
Sources and full results
Most relevant research papers on this topic